Novo Nordisk's Obesity Drugs Exceed ICER’s Cost Effectiveness Thresholds

Draft Report From Pricing Watchdog Calls Out Wegovy, Saxenda

 
• By Jessica Merrill
  
magnified money
A ICER report is taking a closer look at obesity drug prices • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Drug Pricing

More from Scrip